Bionest

Increasing Role for PET

Positron emission tomography (PET) has become widely used for cardiac disease and several cancers. New sensitive antigen-specific tracers are further extending PET usefulness in other settings, including prostate cancer and Alzheimer’s disease (AD).

Bionest

Medical Device Technology and CNS Diseases

Deep brain stimulation, pulsed stimulation and wearable tremor-control devices... see how medical devices are transforming the treatment of central nervous system & psychiatric disorders.

Bionest

Growing Influence of Artificial Intelligence Throughout Pharma

Pharma’s use of artificial intelligence and machine learning is growing quickly. How and when should these tools be incorporated? We explore applications in target identification, drug discovery and optimization, clinical trials, manufacturing & commercialization.

Bionest

What We’re Watching for in 2021 – Part 2 of 2

In our second post exploring trends we expect in the biotech and pharmaceutical development world in 2021, we take a look at digital health, the continuing impact of COVID-19, and growth in pharma investment.

Bionest

Is it COVID-19? Flu? Or Perhaps, Both?

With flu season rapidly approaching, concerns are growing about the risks of a double coronavirus-influenza pandemic that could further overwhelm hospitals and other health care resources.

Bionest

Increased Focus on the Tumor Immune Environment

Researchers are looking to map and describe the workings of the tumor immune environment to find ways to potentiate an immune response or counteract immunosuppressive signals.